BTG Share News (BTG)

BTG Information

There is currently no data for BTG

BTG's emphysema treatment struck down by FDA

Thu, 09th Aug 2018 09:04

(Sharecast News) - Global specialist healthcare company BTG on Thursday received confirmation from the US food and drug administration (FDA) that its emphysema treatment will not receive pre-market approval.The company's Elevair Endobronchial Coil System, which was designed to treat patients suffering severe symptoms, had previously failed to receive backing from the FDA's anaesthesiology and respiratory therapy devices panel of the medical devices advisory committee in June.The company had initially reacted by committing to generating clinical data to support its assessment that had "a role to play" in the management of patients with severe emphysema who had few treatment options.But analysts at Peel Hunt said that investors had likely already written off the London-listed company's product for the US market on account of the earlier failing."As such this news will have little impact on estimates or valuation, but might be a small incremental negative for sentiment as it reinforces the difficulty BTG is experiencing in its attempt to pivot the group to interventional medicine amid the decline of its other two more legacy divisions," Peel said.The coils, which are known as PneumRX Coils in Europe, are designed to be permanently implanted in the most emphysema-damaged parts of the lung to allow more efficient contraction that helps assist the breathing cycle.BTG shares were down 1.90% to 515.00p at 0828 BST.

More News

15 Dec 2015 13:58

BTG rallies as RBC hails long-term growth prospects

(ShareCast News) - RBC Capital Markets initiated coverage of specialist pharmaceutical company BTG at 'outperform' with a price target of 820p, saying it should be a long-term holding. It said the shares have underperformed materially over the past year and, while medium-term market expectations are

15 Dec 2015 09:46

BROKER RATINGS SUMMARY: Berenberg Upgrades Meggitt To Buy From Hold

14 Dec 2015 09:33

BROKER RATINGS SUMMARY: Goldman Sachs Upgrades Fresnillo To Buy

14 Dec 2015 08:38

LONDON MARKET OPEN: BG And Shell Rise On Chinese Regulator Approval

14 Dec 2015 08:14

BTG wins US approval for BC Bead Lumi

(ShareCast News) - Specialist pharmaceutical firm BTG said it had won US regulatory approval for its LC Bead Lumi radiation treatment. The company added that a trial of its PneumRx endobronchial coil implant for severe emphysema had produced positive results with all primary and secondary endpoints

14 Dec 2015 07:45

BTG Gets Positive PneumRx Study Results, LC Bead LUMI Clearance

11 Dec 2015 18:10

BTG Says WellStat Therapeutics' Vistogard Approved In US

13 Nov 2015 09:49

BROKER RATINGS SUMMARY: Davy Expects Lloyds To Outperform

11 Nov 2015 09:32

BROKER RATINGS SUMMARY: JPMorgan And S&P Capital IQ Positive On ITV

10 Nov 2015 10:28

WINNERS & LOSERS SUMMARY: Experian And Vodafone Lead Blue-Chip Risers

10 Nov 2015 08:03

BTG's interim profit soars thanks to solid growth across the board

(ShareCast News) - Healthcare group BTG has posted an increase in interim pre-tax profit, boosted by solid growth across all of its divisions. In the six months to 30 September, the FTSE 250 group posted a 40.6% year-on-year increase in pre-tax profit to £52.9m, while revenue rose 20% to £229.6m. T

10 Nov 2015 07:51

BTG First Half Profit Rises As All Segments Experience Revenue Rise

3 Nov 2015 16:35

Earnings, Trading Statements Calendar - Week Ahead

28 Oct 2015 13:50

FTSE 250 movers: Just Retirement boosted by CMA merger clearance

(ShareCast News) - After an initial stumble, the FTSE 250 fought its way back into positive territory over the day, By 1420 GMT, the UK mid-cap index was up 0.28% at just over 17,000 points, but not rising as fast as its blue chip sister index 0.85% gain. Pharmaceutical group BTG was given a shot i

7 Oct 2015 13:46

FTSE 250 movers: Miners and energy stocks rally; Wizz Air crashes

(ShareCast News) - London's FTSE 250 index was down 0.2% at 17,101.89 just after 1400 BST, underperforming the broader market. Miners were firmly on the front foot as metals prices advanced and the sector got a boost from an upbeat note by Morgan Stanley. The bank upgraded its stance on the European

Latest Share Chat

BTG Share News (BTG)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BTG's emphysema treatment struck down by FDA

Login to your account

Quickpicks are a member only feature

Login to your account